Plasma Growth Factors in Pain A New Dimension of Treatment | Biomedgrid

Pain control has become a medical discipline that costs million dollars to administration in medication, health care and work disability every year. Analgesic units often have difficulty controlling the related pain symptoms in patients, that translates into repeated consultations and hospital admissions with disappointing results for the professionals involved and desperate for the patients who suffer. Without a doubt, the most frequent cause of pain related consultation and functional disability units is related to mechanical low back pain of both traumatic and degenerative origin. Only in the year 2018 it costed to coffers of the US administration about 500 million dollars. In this sense, although rehabilitation is one of the fundamental pillars for the therapeutic approach of these patients, residual pain is a symptom that is often difficult to treat.